Pfizer Lifts Outlook on Covid-19 Vaccine, Posts Weaker Profit

The pharmaceutical company said it expects to generate about $15 billion in sales for its Covid-19 vaccine this year as it posted higher quarterly revenue, but missed on profit expectations to finish 2020.The pharmaceutical company said it expects to generate about $15 billion in sales for its Covid-19 vaccine this year as it posted higher quarterly revenue, but missed on profit expectations to finish 2020.Read MorePAIDWSJ.com: US Business